Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown that this can be painful.

| More on:
The Motley Fool

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt, which would be yet another catastrophe for shareholders. To save itself from that fate, it is currently negotiating with its lenders to ease covenants.

But this has consequences too, as has been demonstrated by a number of oil companies. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) is one example. We’ll take a closer look below.

Valeant’s covenants

According to Valeant’s credit agreement, a default will occur if Valeant doesn’t file its 10-K (which includes audited financial statements) by the end of this month. In that scenario, Valeant will then have 30 days to cure the default by filing its 10-K.

Meanwhile, Valeant has already breached the reporting covenant in its bond indentures, which required a 10-K by March 16. As a result, the company is restricted from borrowing any more money from its revolver.

These aren’t the only covenants Valeant must adhere to; there are also certain financial targets that the company must maintain. The company said it expects to be in compliance with all covenants this year and next, but until the company releases audited financials, it’s impossible to know for sure.

Penn West’s experience

At the beginning of last year Penn West was about to breach its debt covenants, which would have meant a default. To avoid such a fate, the company got lenders to relax covenants. And even though an agreement was reached, it was not a fun process.

For starters, Penn West had to lower its quarterly dividend from $0.03 to $0.01. The company also had to cancel a $500 million tranche in its bank facility. It also had to grant floating charge security over all its property. If that wasn’t bad enough, Penn West had to pledge that any asset sales would go towards reducing debt. To top it all off, the company had to agree to higher interest payments.

Anything can happen

This situation with Valeant is a little different, because Valeant hasn’t even released audited financials, making the outcome very unpredictable. Otherwise, Penn West’s experience provides a useful learning experience.

And anonymous sources have already told Reuters that “creditors prepare to slam company with tougher demands” in exchange for relaxing covenants. So one way or another, Valeant is in for a rough ride. This story is far from over.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

woman checks off all the boxes
Dividend Stocks

5 CRA Red Flags to Watch in Retirement Tax Returns

A few common retirement-return mistakes can trigger CRA follow-up, and most are avoidable with a quick pre-filing checklist.

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Bank Stocks

1 Canadian Stock That Comes Close to Perfect as a Long-Term Hold

Fairfax Financial (TSX:FFH) combines a resilient insurance business with disciplined investing and smart capital allocation, making it one of the…

Read more »

A worker overlooks an oil refinery plant.
Dividend Stocks

An Ideal TFSA Stock With a Steady 4.4% Yield

Here's why this defensive growth stock offering a yield of roughly 4.4% today is such an ideal investment for a…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Tech Stocks

What Are the Best High-Growth Canadian Stocks to Buy Now?

Three Canadian growth stocks look compelling, but they’re priced for success, so gradual buying and position sizing matter.

Read more »

Dividend Stocks

3 Undervalued Canadian Dividend Stocks to Buy Now and Hold for Years

Three Canadian value ideas offer a mix of growth, income, and a real-asset discount, without relying on a “too-good-to-be-true” yield.

Read more »

House models and one with REIT real estate investment trust.
Dividend Stocks

1 Dividend Stock I’d Feel Good About Owning for the Next 7 Years

Choice Properties REIT offers a reliable 4.8% yield backed by Loblaw leases. Here is why this Canadian dividend stock is…

Read more »

holding coins in hand for the future
Dividend Stocks

My 2 Favourite Stocks for Monthly Passive Income

Unlock the potential of monthly dividends with Canadian stocks, focusing on REITs and royalty companies for consistent cash flow.

Read more »

hand stacks coins
Dividend Stocks

3 Dividend Stocks Yielding +4% Canadians Can Own Even When Growth Falls Out of Favour

These three dividend stocks are worth considering for passive income and long-term growth, particularly on market dips.

Read more »